Biodexa Pharmaceuticals (BDRX) Debt to Equity (2012 - 2025)
Biodexa Pharmaceuticals (BDRX) debt to equity from Dec 31, 2012 to Jun 30, 2025. The current Biodexa Pharmaceuticals (BDRX) debt to equity is 4.37%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Biodexa Pharmaceuticals (BDRX)
| Year | Debt to Equity | Change |
|---|---|---|
| 2024 | 8.77% | -10.73% |
| 2023 | 9.83% | -49.90% |
| 2022 | 19.62% | +166.27% |
| 2021 | 7.37% | +90.45% |
| 2020 | 3.87% | -87.55% |
| 2019 | 31.08% | +320.75% |
| 2018 | 7.39% | -60.88% |
| 2017 | 18.89% | +299.77% |
| 2016 | 4.72% | +13.60% |
| 2015 | 4.16% | -9.99% |
| 2014 | 4.62% | -98.96% |
| 2013 | 443.42% | N/A |
| 2012 | 0.00% | N/A |
Comparison Biodexa Pharmaceuticals (BDRX) debt to equity with competitors
Biodexa Pharmaceuticals (BDRX) debt to equity is 4.37%.